EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Evogene Ltd. (EVGN) had EBIT Margin of -347.40% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.88M |
|
$-4.46M |
|
$0.14M |
|
$0.75M |
|
$3.96M |
|
$-3.07M |
|
$-0.46M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-4.68M |
|
$-4.68M |
|
$-3.53M |
|
$-3.07M |
|
$-2.72M |
|
7.23M |
|
7.23M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$28.64M |
|
$1.36M |
|
$5.28M |
|
$33.93M |
|
$15.19M |
|
-- |
|
$6.36M |
|
$21.55M |
|
$12.38M |
|
$12.38M |
|
$12.38M |
|
8.71M |
|
| Cash Flow Statement Financials | |
$-7.48M |
|
$-3.43M |
|
$3.99M |
|
$15.30M |
|
$8.33M |
|
$-6.97M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
84.62% |
|
-347.40% |
|
|
EBIT Margin |
-347.40% |
-- |
|
-399.10% |
|
-504.75% |
|
$-7.61M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.07 |
|
0.49 |
|
182.24 |
|
-37.83% |
|
-37.83% |
|
-13.80% |
|
-37.83% |
|
$1.42 |
|
$-1.05 |
|
$-1.04 |
|